Apple Tree Partners (ATP)
Apple Tree Partners (ATP) is a leading venture capital firm specializing in life sciences, with a focus on developing transformative biotechnology companies. Founded in 1999, ATP has $2.9 billion in committed capital and operates from offices in New York, South San Francisco, and Cambridge, MA. The firm is dedicated to creating and investing in companies at various stages, from pre-IP ideas to asset spinouts, and supports them from seed stage through IPO and beyond. ATP's strategy centers on providing flexible capital and access to a world-class team to build sustainable, research-driven enterprises that improve human lives.
Apple Tree Partners (ATP)
230 Park Avenue, Suite 2800, New York, New York 10169
What We Do
ATP provides flexible capital to its portfolio companies, supporting them from seed stage through IPO and beyond.
ATP offers strategic insight and operational resources to build sustainable, research-driven enterprises.
ATP supports management teams in strategic transactions and synergistic business combinations.
Portfolio
Develops novel antibodies targeting T cell receptor variants to boost anti-tumor T cells.
#Biotechnology
Develops medical devices for pulmonary diseases, including the RheOx system for chronic bronchitis.
#Medical Devices
Focuses on discovering small-molecule therapeutics for movement disorders using computational chemistry and machine learning.
#Biotechnology
Develops IL-2 therapeutics for cancer treatment, leveraging computationally designed antibodies.
#Biotechnology